Antoine G. Van Der Heijden

Rotterdam, ZH 3015GD, Netherlands

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 115 publications

Response evaluation of neoadjuvant therapy in MIBC: clinical trial-derived evidence to guide practice.

Response evaluation of neoadjuvant therapy in MIBC: clinical trial-derived evidence to guide practice.

Journal: BJU international

Published: August 05, 2026

Correction: Pérez et al. Biomarker-Based Nomogram to Predict Neoadjuvant Chemotherapy Response in Muscle-Invasive Bladder Cancer. Biomedicines 2025, 13, 740.

Correction: Pérez et al. Biomarker-Based Nomogram to Predict Neoadjuvant Chemotherapy Response in Muscle-Invasive Bladder Cancer. Biomedicines 2025, 13, 740.

Journal: Biomedicines

Published: July 03, 2026

Comprehensive genome-wide association study into multiple recurrence and progression risk in non-muscle invasive bladder cancer.

Comprehensive genome-wide association study into multiple recurrence and progression risk in non-muscle invasive bladder cancer.

Journal: Cancer genetics

Published: May 05, 2026

Surveillance patterns in non-muscle-invasive bladder cancer across risk groups: a real-world analysis.

Surveillance patterns in non-muscle-invasive bladder cancer across risk groups: a real-world analysis.

Journal: BJU international

Published: April 23, 2026

Re: Twelve-month Results from the CISTO Study Comparing Radical Cystectomy Versus Bladder-sparing Therapy for Recurrent High-grade Non-muscle-invasive Bladder Cancer: Recurrent High-risk NMIBC: One Bladder, Choose Wisely.

Re: Twelve-month Results from the CISTO Study Comparing Radical Cystectomy Versus Bladder-sparing Therapy for Recurrent High-grade Non-muscle-invasive Bladder Cancer: Recurrent High-risk NMIBC: One Bladder, Choose Wisely.

Journal: European urology

Published: April 22, 2026

Lifestyle and dietary inflammation scores and risks of recurrence and progression among patients with non-muscle invasive bladder cancer.

Lifestyle and dietary inflammation scores and risks of recurrence and progression among patients with non-muscle invasive bladder cancer.

Journal: Nutrition (Burbank, Los Angeles County, Calif.)

Published: April 17, 2026

Fruit and vegetable consumption, dietary and plasma carotenoids and risks of recurrence and progression in patients with non-muscle-invasive bladder cancer.

Fruit and vegetable consumption, dietary and plasma carotenoids and risks of recurrence and progression in patients with non-muscle-invasive bladder cancer.

Journal: European journal of nutrition

Published: February 12, 2026

Treatments and survival outcomes of patients with synchronous and metachronous metastatic bladder cancer: A population-based nationwide cohort study.

Treatments and survival outcomes of patients with synchronous and metachronous metastatic bladder cancer: A population-based nationwide cohort study.

Journal: Cancer treatment and research communications

Published: November 03, 2025

Recurrence Patterns in a Large Contemporary Cohort of Patients With Non-Muscle Invasive Bladder Cancer.

Recurrence Patterns in a Large Contemporary Cohort of Patients With Non-Muscle Invasive Bladder Cancer.

Journal: Clinical genitourinary cancer

Published: August 20, 2025

Multiparametric MRI for local staging in patients with suspected muscle-invasive bladder cancer: study protocol for a multicentre, non-inferiority randomised controlled trial (the BladParadigm study).

Multiparametric MRI for local staging in patients with suspected muscle-invasive bladder cancer: study protocol for a multicentre, non-inferiority randomised controlled trial (the BladParadigm study).

Journal: BMJ open

Published: August 17, 2025

Addressing Uneven Treatment Discontinuation Rate in the Chemotherapy Arm of the EV-302 Phase 3 Randomized Clinical Trial: Implications for Outcome Interpretation.

Addressing Uneven Treatment Discontinuation Rate in the Chemotherapy Arm of the EV-302 Phase 3 Randomized Clinical Trial: Implications for Outcome Interpretation.

Journal: Clinical genitourinary cancer

Published: August 01, 2025

Final clinical analysis of pre-operative ipilimumab and nivolumab in locally advanced urothelial cancer and exploration of tumor-draining lymph node composition: The NABUCCO trial.

Final clinical analysis of pre-operative ipilimumab and nivolumab in locally advanced urothelial cancer and exploration of tumor-draining lymph node composition: The NABUCCO trial.

Journal: European journal of cancer (Oxford, England : 1990)

Published: May 30, 2025

Showing 1-12 of 115

Last Updated: 09/26/2026